27 Jun OAFI supporting #BCN4EMA
- Osteoarthritis Foundation International (OAFI) supports Barcelona’s candidacy to host the European Medicines Agency
OAFI, the Osteoarthritis Foundation International, teams up with more than 200 social, economic and cultural institutions that sign a manifesto to express their support for Barcelona to host the European Medicines Agency (EMA).
EMA is the European institution responsible for the scientific evaluation, supervision and safety monitoring of medicines in the EU. EMA protects public and animal health in 28 EU Member States, as well as the countries of the European Economic Area, by ensuring that all medicines available on the EU market are safe, effective and of high quality. It serves a market of over 500 million people living in the EU.
The spirit of cooperation between the Government of Spain, the Government of Catalonia and Barcelona City Council in jointly promoting the candidacy is outstanding in order to achieve this goal.
According to the signed manifesto, the experience and capabilities of Barcelona will ensure that the Agency’s relocation will be quick and efficient. The ideal conditions will be in place to secure the continuity of current programmes and projects. In addition, the city’s scientific, technological and industrial potential mean that it has the appeal to retain talent and will facilitate scientific excellence.
Barcelona is currently the main research hub for Southern Europe. It has a wide network of outstanding institutions, universities and biomedical, hospital and technological research centres. This scientific strength is a major reason why Spain is ranked second in Europe in the number of clinical trials for advanced therapies, with a significant increase in the last decade. The city also has a robust information and communication technology ecosystem.
The Heads of State’ Council and EU Government will decide next November where the EMA will be located. Until now, its headquarters are in London but due to the result of Brexit, EMA is looking for a new location.
Barcelona competes with 21 European cities to host the EMA. Copenhagen, Stockholm, Amsterdam, Vienna, Milan and Lille are the main competitors.
“The priority criterion for the EU when choosing the city that will host the EMA is that the transfer will involve the least possible loss of talent and that the agency will not interrupt its activity,” says Jordi Ramentol, vice president of Farmaindustria. Barcelona covers both requirements perfectly. If institutional unity persists we can achieve this. ”
With the EMA, Barcelona has the opportunity to consolidate itself as a global reference in innovation, industry and health on a global scale, attracting quality jobs, companies, talent, employment opportunities and more income for the city.